FDA
label_change
· 2022-12-14
FDA Approved: CLONAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
The FDA approved a supplemental application for clonazepam filed by Teva Pharmaceuticals USA, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CLONAZEPAM (CLONAZEPAM)